CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
July 8th 2025
My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and downs.
FDA Approves Herceptin Biosimilar for Breast Cancer Treatment
December 15th 2018The FDA has approved Herzuma (trastuzumab-pkrb) (Herzuma) as a biosimilar to Herceptin (trastuzumab, Genentech). Trastuzumab-pkrb is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer.